Clinical trial
All-Russian Observational Non-interventional Study on Efficacy and Safety of Divaza in Patients With Chronic Cerebral Ischemia and Cognitive Disorders
NCT04370028 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- All-Russian Observational Non-interventional Study on Efficacy and Safety of Divaza in Patients With Chronic Cerebral Ischemia and Cognitive Disorders
- Lead sponsor
- Materia Medica Holding
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2016
- Completion date
- January 31, 2017
- Enrollment
- 2,583 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
chronic cerebral ischemia